TP53 and cancer: For example, OGT activity was shown to upregulate miR-483-3p expression, and to potentially have an oncogenic role in cancer by glucose uptake, but at the same time, was shown that inhibition of OGA, the enzyme that catalyzes O-GlcNAc hydrolysis, stabilizes TP53 from degradation in cancer [113].